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Abstract
Background: Radiotherapy of the thorax often causes lung inflammation leading to fibrosis.
Objectives: The aim of this study was to investigate whether the use of glycyrrhizic acid (GLA) could improve the development of
lung fibrosis in irradiated animals.
Materials and Methods: Wistar rats were divided into four groups. Group A rats received thoracic irradiation. Rats in group B
received GLA and irradiation. Group C received GLA and no irradiation. Group D received no GLA and irradiation. GLA was adminis-
tered at a dose of 4 mg/kg body weight using an intraperitoneal injection one hour before thoracic irradiation. Radiation therapy
was delivered on a Cobalt-60 unit using a single fraction of 16 Gy. The animals were sacrificed at 32 weeks following thoracic irradi-
ation. The lungs were dissected and blind histopathological evaluation was performed.
Results: Histopathologically, a decrease (statistically not significant) in the thickening of alveolar or bronchial wall, formation of
fibrous bands, and superimposed collagen were noted in the animals in group B as compared to the animals in group A.
Conclusion: In this experimental study, administration of GLA one hour before thoracic irradiation may be a protective agent
against radiation-induced fibrosis in animals and this model could be used in future studies.
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1. Background
The lung as a radiosensitive organ of the body imports
a problem for radiotherapy of the thorax (1). The lung’s re-
action to radiation in animal models and human are sim-
ilar and can be divided into acute and chronic phases. It
is reported that these reactions are not necessarily related;
therefore, the chronic phase can appear without being pre-
ceded by the acute phase. Radiation induced-acute pneu-
monitis and chronic fibrosis develop within 6 months and
6 - 12 months, respectively to radiation doses≥ 8 Gy. Acute
phase involves edema of the alveolar spaces, with increas-
ing infiltration of mononuclear and inflammatory cells in
the alveolar spaces. The chronic phase involves repair pro-
liferation of alveolar cells that leads to changes in connec-
tive and vascular tissue (2). Radiation-induced lung dam-
age is a common and critical difficulty that restricts the
doses that can be released in radiation therapy (3). Stud-
ies have shown that radiation-induced pulmonary fibro-
sis is caused by a fixed remodeling of fibrous tissue and
long-time fibroblast activation (4-7). It seems that pro-
inflammatory and profibrotic cytokines, oxidative stress,
vascular injury, and coagulation cascade have an essential
role in the progress of radiation fibrosis (8-10). Some stud-
ies suggest that radiation causes a high production of re-
active oxygen species (ROS), which may be related to tissue
hypoxia. ROS induces a cascade of cytokines and this has
a central role in the non-healing wound response that per-
petuates lung damages (11-14). Therefore, biological mod-
ifiers, such as antioxidants, have been studied to manip-
ulate this process to minimize the progress of radiation-
induced lung fibrosis. A massive matter in the evalua-
tion of radioprotective agents potential benefit during ra-
diation exposure is the development of radioprotectors
(15). Root extracts of the plant Glycyrrhiza glabra L. known
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as Yashtimadhu, in Ayurveda have been used to cure dif-
ferent illnesses because of its anti-inflammatory, antibac-
terial, and immune-modulating properties (16). The ac-
tive compounds of the extract have been reported to have
an immune-modulating antioxidant. One famous compo-
nent of the extract is glycyrrhizic acid (GLA), a triterpenoid
saponin glycoside (Figure 1) (17-19). There are different an-
tioxidant compounds in liquorice root and the literature
supports that a wide range of pharmacological properties
such as anticarcinogenic and anti-immune-mediated cyto-
toxicity is seen in the GLA (20).
Figure 1. Schematic chemical structure of glycyrrhizic acid (GLA)
2. Objectives
In this study we tested the hypothesis that GLA can alter
the progress of radiation- induced lung fibrosis by acting
as an antioxidant by scavenging ROS.
3. Materials andMethods
3.1. Animals
Twenty male Wistar rats weighting about 190 g were
used in this study. The animals were obtained from
the vivarium section of the department of pharmacology,
Tehran University of Medical Sciences. Five of these rats
were housed together in metal wire netting cages, with the
room temperature maintained at 20 - 22°C, relative humid-
ity of 50% - 70%, and an airflow rate of 15 exchange/hour, to
12 hours alternate light and dark cycle. Animals had free
access to tap-water in glass bottles and standard rat chow.
All the procedures in this study are in accordance with the
guidelines for care and use of laboratory animals, adopted
by the ethics committee of Tehran University of Medical
Sciences (210/27686, Nov3, 2002).
3.2. Radiation Schedule
Prior to irradiation, the animals in groups A and B
were anesthetized with an intraperitoneal (IP) injection of
ketamine hydrochloride, 80 mg/kg body weight, and xy-
lazine, 5 mg/kg body weight (Alfasan, Woerden-Holland).
Positioning was facilitated using a Lucite fixation setup,
making it possible to irradiate five animals simultane-
ously. The animals were in the supine position and the
whole thoracic region was irradiated by a Cobalt-60 unit
(Theratron 780, AE Canada Ltd., Canada) at a depth of 1 cm,
at a focuse-thoracic cage distance of 80 cm, and single dose
of 16 Gy, with a dose rate of 99/84 cGy/min. Following radia-
tion, the animals were closely observed until recovery from
anesthesia.
3.3. Experimental Protocol
Animals were randomized into four experimental
groups with five rats per group. The first group of animals
(group A) had irradiation to the thoracic region. The sec-
ond group of animals (group B) had thoracic irradiation
plus GLA. The third group (group C) had GLA. The fourth
group (group D) had no thoracic irradiation and GLA.
Group B and C received GLA (4 mg/kg body weight in
double distilled water) via IP injection (21) one hour before
irradiation.
3.4. Histopathological Evaluation
The animals underwent euthanasia at 32 weeks follow-
ing irradiation. Prior to euthanasia, the animals received
anesthesia using ketamine 50 mg/kg administered using
an IP injection. Euthanasia was performed by transcar-
diac perfusion using 0.9% sodium chloride. The animals
were sacrificed and their chests were opened immediately
for access and examination of the lungs. The lungs were
dissected, instilled with 10% buffered formaldehyde, kept
in 10% buffered formaldehyde for 24 hours, embedded in
paraffin, sliced into 5µm thick sections, and stained using
hematoxylin and eosin (H& E). The histological examina-
tion was performed by a histologist, who was blinded to
the experimental protocol, and viewed under the light mi-
croscope (LM), (BX50, Olympus Corporation, Tokyo, Japan)
using a grid system. The term “fibrotic” as a morphological
term was used to explain an increase of connective tissue
fibers under the light microscope in response to some in-
sult. The pathologist uses the characteristic staining prop-
erties of collagenous ingredients of the fibrous tissue (2).
In this study, fibrosis was defined as the thickened alveolar
walls with superimposed collagen. As a quantitative end
point, the extent of radiation-induced fibrosis was scored
on a scale of 0 (normal lung) to 3 (severe superimposed col-
lagen) as described in Table 1 (3). After assessment of all the
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sections for each animal, the minimum (min) and maxi-
mum (max) fibrosis score and median values of the groups
were calculated.
Table 1. Criteria for Scaling of Lung Fibrosis
Scale of Fibrosis Histological Features
0 Normal lung
1 Mild thickening of alveolar or bronchial wall
2 Formation of fibrous bands
3 Severe superimposed collagen
3.5. Statistical Analysis
The results are represented as min, max and median.
Statistical analyses were performed using the Kruskal Wal-
lis test and the Mann-Whitney U test contained in the SPSS
software package (version 11.0) for windows 98 (SPSS Inc.,
Chicago, Ill, USA). A probability value less than 0.05 was
considered significant.
4. Results
At the end of the histological examination, it was seen
that animals in groups A and B had pulmonary fibrosis
(Figures 2-5). The descriptive data for each group is shown
in Table 2.
Kruskal Wallis test showed a significant difference
among the four groups (P < 0.001). When group A was
compared with group D, the difference was statistically sig-
nificant with the Mann- Whitney U test (P < 0.001).
When group A was compared with group B, the differ-
ence was statistically significant with the Mann-Whitney U
test (P = 0.002). When group B was compared with group D,
the difference was statistically significant with the Mann-
Whitney U test (P < 0.001). When group A was compared
with group C, the difference was statistically significant
with the Mann-Whitney U test (P < 0.001). When group
B was compared with group C, the difference was statisti-
cally significant with the Mann-Whitney U test (P < 0.001).
No significant differences were observed between groups
C and D with the Mann-Whitney U test (P = 0.785).
5. Discussion
Radiation therapy as a treatment modality is widely
used in the management of cancer. Radiation induced-
fibrosis is a serious part of the spectrum of radiation dam-
age and at the present time, cure for this condition is lim-
ited (22). The radioprotective agents can elicit their ac-
tion by various mechanisms. Numerous pharmacologic
effects of GLA include anti-inflammatory, anti- tumor and
antioxidant properties. The broad spectrum of pharma-
cological activity inherent in this extract is confirmed by
results of traditional investigations, which include anti-
inflammatory, antiviral, and immunomodulant (23). Af-
nan et al. (2012) indicated that GLA as a natural and safe
photoprotective agent might be useful against UVB irradia-
tion (24). Ward et al. (1990) demonstrated that the cellular
injury associated with radiation therapy is predominately
brought about as the result of the unstable ROS that are in
constant reaction with the cellular DNA content (25).
Another study conducted by Kumar et al. (1988) in-
dicated that activation of the antioxidant defense system
needs protection against the damaging effects of the un-
stable ROS (26). There has been a continued interest for the
identification of a safe and effective protectant that bears
the potential to function as the scavenger of the unstable
ROS and down-regulates the cellular injury associated with
radiation therapy (27).
In the present study, in the group of animals that were
administrated GLA and thoracic irradiation, a reduction in
fibrosis was achieved, the difference was statistically signif-
icant when compared with the group of animals that had
only received thoracic irradiation (Figures 2 and 3). When
animals of group B that received thoracic irradiation and
GLA were compared with animals of group D that received
no GLA and thoracic irradiation, the difference was statisti-
cally significant. This issue may result in administration of
low dose GLA. Therefore, it seems that long- term adminis-
tration of GLA and other concentrations of this extract may
produce more protection against radiation-induced lung
fibrosis. However, many in vivo and in vitro examinations
and clinical trials on this topic are still necessary for valida-
tion.
Figure 2. Histological lung tissue section of a rat from group A (H & E× 400)
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Table 2. Descriptive Data in Four Groupsa
Groups Median Minimum Maximum Mann-Whitney U Test P Valueb
A 3 2 3 A vs B: P = 0.002; A vs C: P < 0.001; A vs D: P < 0.001
B 2 2 3 B vs A: P = 0.002; B vs C: P < 0.001; B vs D: P < 0.001
C 0 0 1 C vs A: P < 0.001; C vs B: P < 0.001; C vs D: P = 0.785
D 0 0 1 D vs A: P < 0.001; D vs B: P < 0.001; D vs C: P = 0.785
aGroups: group A, thoracic irradiation only; group B, thoracic irradiation plus glycyrrhizic acid (GLA); group C, GLA only; Group D, no thoracic irradiation and GLA.
bDifference was regarded significant if P < 0.05.
Figure 3. Histological lung tissue section of a rat from group B (H & E× 400)
Figure 4. Histological lung tissue section of a rat from group C (H & E× 400)
The results of the current study show that GLA
may have a protective effect against radiation induced
lung injury, as assessed by the severity of fibrosis using
Figure 5. Histological lung tissue section of a rat from group D (H & E× 400)
histopathology. We could not find reports of the effective-
ness of GLA as a protectant against lung injury induced
by radiation therapy to compare with our results. But
there are reports about radioprotective effects of GLA on
different cells in vitro and ex vivo. Shetty et al. (2002)
found that the root extract of Glycyrrhizia glabra L. pro-
tects microsomal membranes, as evident from reduction
in lipid peroxidation, and it also protects DNA from
radiation-induced strand breaks (28). Gandhi et al. (2004)
implicated that an IP administration of GLA one hour
before exposure to gamma radiation protected cellular
DNA from radiation-induced strand breaks in periph-
eral blood leukocytes and bone marrow cells. Also, they
demonstrated that pulse radiolysis studies indicated that
GLA offered radioprotection by scavenging free radicals
(21). Rossi et al. (2005) showed that use of GLA might lead
to protection from the damage induced in humans by
UVB radiation (20). Today there is a lot of interesting data
on the prevention of radiation-induced lung injury, but
none of it has so far been shown to be effective in a clinical
setting. Previous studies showed effectiveness of radiopro-
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tectors such as WR-2721, vitamin E, captopril, melatonin,
and genistein on radiation-induced lung injury (1, 3, 29-31).
It seems that the combination of GLA with some radiopro-
tectors may be useful in the mitigation effect of radiation
on lung tissue. The incidence of radiation-induced injuries
might reduce GLA administration to patients undergoing
medical radiation. These findings suggest that the radio-
protective effect of GLA on lung tissue should be studied
in detail before translating the results of the present
experimental study into clinical trials in order to alter the
therapeutic index of radiation treatment. A single dose of
GLA could be a limitation of this study. It is recommended
that further studies with different doses of GLA should be
performed to examine the radioprotective effect of GLA in
the lung tissue in more detail.
In conclusion, according to this experimental study,
administration of GLA one hour before thoracic irradia-
tion may be a protective agent against radiation-induced
fibrosis in animals and this model could be used in future
studies.
Acknowledgments
We thank the Cancer Institute of Tehran University of
Medical Sciences for their excellent assistance with the ir-
radiation of the animals.
Footnotes
Authors’ Contributions: Abbas Takavar and Soheila Re-
fahi contributed to all parts of the study especially sam-
pling, sacrificing, radiotherapy, data analysis and writing
the manuscript. Bagher Minaei and Samideh Khoei con-
ducted histopathology examination. Masoud Pourissa and
Azam Bakhtiarian contributed to writing the manuscript.
Gholam Hassan Haddadi developed the original idea and
the protocol.
Financial Disclosure: There are no financial disclosures
or conflicts of interest in this study.
Funding/Support: The work of authors is supported by
grant No. 17951 from the vice chancellor of research at
Tehran University of Medical Sciences, Tehran, Iran.
References
1. Calveley VL, Jelveh S, Langan A, Mahmood J, Yeung IW, Van Dyk J,
et al. Genistein can mitigate the effect of radiation on rat lung tis-
sue. Radiat Res. 2010;173(5):602–11. doi: 10.1667/RR1896.1. [PubMed:
20426659].
2. Coggle JE, Lambert BE, Moores SR. Radiation effects in the lung. Envi-
ron Health Perspect. 1986;70:261–91. [PubMed: 3549278].
3. Bese NS, Munzuroglu F, Uslu B, Arbak S, Yesiladali G, Sut N, et al. Vi-
tamin E protects against the development of radiation-induced pul-
monary fibrosis in rats. Clin Oncol (R Coll Radiol). 2007;19(4):260–4.
doi: 10.1016/j.clon.2006.12.007. [PubMed: 17433970].
4. Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radia-
tion on normal tissue: consequences and mechanisms. Lancet Oncol.
2003;4(9):529–36. [PubMed: 12965273].
5. Finkelstein JN, Johnston CJ, Baggs R, Rubin P. Early alterations in ex-
tracellular matrix and transforming growth factor beta gene expres-
sion in mouse lung indicative of late radiation fibrosis. Int J Radiat On-
col Biol Phys. 1994;28(3):621–31. [PubMed: 8113105].
6. Rodemann HP, Bamberg M. Cellular basis of radiation-induced fibro-
sis. Radiother Oncol. 1995;35(2):83–90. [PubMed: 7569029].
7. Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN. A per-
petual cascade of cytokines postirradiation leads to pulmonary fibro-
sis. Int J Radiat Oncol Biol Phys. 1995;33(1):99–109. doi: 10.1016/0360-
3016(95)00095-G. [PubMed: 7642437].
8. Anscher MS, Kong FM, Andrews K, Clough R, Marks LB, Bentel G, et al.
Plasma transforming growth factor beta1 as a predictor of radiation
pneumonitis. Int J Radiat Oncol Biol Phys. 1998;41(5):1029–35. [PubMed:
9719112].
9. Fu XL, Huang H, Bentel G, Clough R, Jirtle RL, Kong FM, et al. Predict-
ing the risk of symptomatic radiation-induced lung injury using both
the physical and biologic parameters V(30) and transforming growth
factor beta. Int J Radiat Oncol Biol Phys. 2001;50(4):899–908. [PubMed:
11429217].
10. Chen Y, Williams J, Ding I, Hernady E, Liu W, Smudzin T, et al. Radia-
tion pneumonitis and early circulatory cytokine markers. Semin Ra-
diat Oncol. 2002;12(1 Suppl 1):26–33. [PubMed: 11917281].
11. Poli G, Parola M. Oxidative damage and fibrogenesis. Free Radic Biol
Med. 1997;22(1-2):287–305. [PubMed: 8958154].
12. Haroon ZA, Raleigh JA, Greenberg CS, Dewhirst MW. Early wound heal-
ing exhibits cytokine surge without evidence of hypoxia. Ann Surg.
2000;231(1):137–47. [PubMed: 10636114].
13. Vujaskovic Z, Anscher MS, Feng QF, Rabbani ZN, Amin K, Samulski TS,
et al. Radiation-induced hypoxia may perpetuate late normal tissue
injury. Int J RadiatOncol Biol Phys. 2001;50(4):851–5. [PubMed: 11429211].
14. Kang SK, Rabbani ZN, Folz RJ, Golson ML, Huang H, Yu D, et al.
Overexpression of extracellular superoxide dismutase protects mice
from radiation-induced lung injury. Int J Radiat Oncol Biol Phys.
2003;57(4):1056–66. [PubMed: 14575837].
15. Arora R, Gupta D, Chawla R, Sagar R, Sharma A, Kumar R, et
al. Radioprotection by plant products: present status and fu-
ture prospects. Phytother Res. 2005;19(1):1–22. doi: 10.1002/ptr.1605.
[PubMed: 15799007].
16. Agarwal SS, Singh VK. Medicinal Plants and Synthetic Peptides Part II:
Synthetic Peptides. P Indian Natl Sci Acad. 1999;65:179–204.
17. Kroes BH, Beukelman CJ, van den Berg AJ, Wolbink GJ, van Dijk H,
Labadie RP. Inhibition of human complement by beta-glycyrrhetinic
acid. Immunology. 1997;90(1):115–20. [PubMed: 9038721].
18. Belinky PA, Aviram M, Mahmood S, Vaya J. Structural aspects of the
inhibitory effect of glabridin on LDL oxidation. Free Radic Biol Med.
1998;24(9):1419–29. [PubMed: 9641259].
19. Vaya J, Belinky PA, Aviram M. Antioxidant constituents from licorice
roots: isolation, structure elucidation and antioxidative capacity to-
ward LDL oxidation. Free Radic Biol Med. 1997;23(2):302–13. [PubMed:
9199893].
20. Rossi T, Benassi L, Magnoni C, Ruberto AI, Coppi A, Baggio G. Ef-
fects of glycyrrhizin on UVB-irradiated melanoma cells. In Vivo.
2005;19(1):319–22. [PubMed: 15796192].
21. Gandhi NM, Maurya DK, Salvi V, Kapoor S, Mukherjee T, Nair CK. Radio-
protection of DNA by glycyrrhizic acid through scavenging free radi-
cals. J Radiat Res. 2004;45(3):461–8. [PubMed: 15613793].
22. Takavar A, Minaei B, Hadadi GH, Khoei S, Refahi S, Behrouzkia Z, et al.
Late histopathological findings in the thoracic irradiation: A prelim-
inary study in the animal model. Life Sci J. 2013;10(7s).
Iran J Radiol. 2016; 13(2):e21012. 5
Refahi S et al.
23. Pavlova SI, Uteshev BS, Sergeev AV. Possible Mechanisms of Antitox-
icant, Anticarcinogen, and Antitumor Properties (A Review). Pharm
Chem J. 2003;37(6):314–7. doi: 10.1023/a:1026005931751.
24. Afnan Q, Adil MD, Nissar-Ul A, Rafiq AR, Amir HF, Kaiser P, et
al. Glycyrrhizic acid (GA), a triterpenoid saponin glycoside al-
leviates ultraviolet-B irradiation-induced photoaging in hu-
man dermal fibroblasts. Phytomedicine. 2012;19(7):658–64. doi:
10.1016/j.phymed.2012.03.007. [PubMed: 22516896].
25. Ward JF. The yield of DNA double-strand breaks produced intracellu-
larly by ionizing radiation: a review. Int J Radiat Biol. 1990;57(6):1141–
50. [PubMed: 1971840].
26. Kumar KS, Vaishnav YN, Weiss JF. Radioprotection by antioxidant
enzymes and enzyme mimetics. Pharmacol Ther. 1988;39(1-3):301–9.
[PubMed: 3059373].
27. Weiss JF, Landauer MR. Radioprotection by antioxidants. AnnN Y Acad
Sci. 2000;899:44–60. [PubMed: 10863528].
28. Shetty TK, Satav JG, Nair CK. Protection of DNA and microsomal
membranes in vitro by Glycyrrhiza glabra L. against gamma irradi-
ation. Phytother Res. 2002;16(6):576–8. doi: 10.1002/ptr.927. [PubMed:
12237818].
29. Merrill WW. Radiation-induced lung injury 2011. Available from:
www.uptodate.com.
30. Serin M, Gulbas H, Gurses I, Erkal HS, Yucel N. The histopathological
evaluation of the effectiveness of melatonin as a protectant against
acute lung injury induced by radiation therapy in a rat model. Int J
Radiat Biol. 2007;83(3):187–93. [PubMed: 17378527].
31. Maasilta P. Radiation-induced lung injury. From the chest physi-
cian’s point of view. Lung Cancer. 1991;7(6):367–84. doi: 10.1016/0169-
5002(91)90388-m.
6 Iran J Radiol. 2016; 13(2):e21012.
